Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ossio
AddedFeb 15, 2024
UpdatedJun 18, 2026
Ossio

Ossio

Series C

Ossio Inc: A medical device company innovating orthopedic fixation with bone regeneration technology.

HQ
Woburn, MA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Ossio Inc, founded with a mission to revolutionize orthopedic care, focuses on developing advanced bone regeneration technology. Their flagship product, OSSIOfiber®, is a bio-integrative implant material designed to securely fixate and fully integrate into the native anatomy, eliminating the need for permanent hardware. Ossio aims to transform the orthopedic experience for patients, physicians, and payors, primarily serving markets in the United States and Israel.

Notable figures affiliated with Ossio include key investors and medical professionals who have endorsed their innovative approach. The company has received multiple awards for its groundbreaking technology, which has been widely recommended by patients. Ossio's impact lies in its ability to offer a superior alternative to traditional metal implants, promoting healthier bone regeneration and improving overall patient outcomes.

Ossio - Similar Companies

Ostiio logo

Ostiio

ostiio.com

OssiFi logo

OssiFi

ossifi.com

OsteoNovus logo

OsteoNovus

osteonovus.com

RevOrtho logo

RevOrtho

revortho.com

OsteoCentric Technologies logo

OsteoCentric Technologies

osteocentric.com

Ossium Health logo

Ossium Health

ossiumhealth.com

Woven Orthopedic Technologies logo

Woven Orthopedic Technologies

Osteovantage logo

Osteovantage

Bone Solutions logo

Bone Solutions

bonesolutions.net

Osseon Therapeutics logo

Osseon Therapeutics

Orthofix logo

Orthofix

orthofix.com

Atreon Orthopedics logo

Atreon Orthopedics

atreonortho.com

Lenoss Medical logo

Lenoss Medical

lenoss.com

Osciflex logo

Osciflex

osciflex.com

Novum Medical logo

Novum Medical

Ossio - Quick Facts

Who are Ossio's competitors?

Companies similar to Ossio include Ostiio, OssiFi, OsteoNovus and RevOrtho.

When was Ossio founded?

Ossio was founded in 2014.

Where is Ossio's headquarters located?

Ossio's headquarters is located in Woburn, MA, US.

When was Ossio's last funding round?

Ossio's most recent funding round was for $38.5M (USD) in October 2022.

How much has Ossio raised to-date?

As of Oct 17, 2022, Ossio has raised a total of $60.5M (USD).

How many employees does Ossio have?

Ossio has 62 employees as of Feb 4, 2024.

Ossio - Classification

Industry
  • Hardware
Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Israel
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 14 more industry codes
NAICS
  • 513200Software Publishers
  • 330000Manufacturing
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified